1α,25-dihydroxyvitamin D3-eluting nanofibrous dressings induce endogenous antimicrobial peptide expression
Nanomedicine, 2018•Future Medicine
Aim: The aim of this study was to develop a nanofiber-based dressing capable of local
sustained delivery of 1α, 25-dihydroxyvitamin D3 (1, 25 (OH) 2D3) and augmenting human
CAMP induction. Materials & methods: Nanofibrous wound dressings containing 1, 25 (OH)
2D3 were successfully prepared by electrospinning, which were examined in vitro, in vivo
and ex vivo. Results: 1, 25 (OH) 2D3 was successfully loaded into nanofibers with
encapsulation efficiency larger than 90%. 1, 25 (OH) 2D3 showed a sustained release from …
sustained delivery of 1α, 25-dihydroxyvitamin D3 (1, 25 (OH) 2D3) and augmenting human
CAMP induction. Materials & methods: Nanofibrous wound dressings containing 1, 25 (OH)
2D3 were successfully prepared by electrospinning, which were examined in vitro, in vivo
and ex vivo. Results: 1, 25 (OH) 2D3 was successfully loaded into nanofibers with
encapsulation efficiency larger than 90%. 1, 25 (OH) 2D3 showed a sustained release from …
Aim
The aim of this study was to develop a nanofiber-based dressing capable of local sustained delivery of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) and augmenting human CAMP induction. Materials & methods
Nanofibrous wound dressings containing 1,25(OH)2D3 were successfully prepared by electrospinning, which were examined in vitro, in vivo and ex vivo. Results
1,25(OH)2D3 was successfully loaded into nanofibers with encapsulation efficiency larger than 90%. 1,25(OH)2D3 showed a sustained release from nanofibers over 4 weeks. Treatment of U937 and HaCaT cells with 1,25(OH)2D3-loaded poly(ε-caprolactone) nanofibers significantly induced hCAP18/LL37 expression in monocytes and keratinocytes, skin wounds of humanized transgenic mice and artificial wounds of human skin explants. Conclusion
1,25(OH)2D3 containing nanofibrous dressings could enhance innate immunity by inducing antimicrobial peptide production.
Future Medicine